Medidata

Medidata is a unified life sciences platform designed to power smarter clinical trials by connecting Patient, Data, and Study Experiences through intelligent technology, AI-driven insights, and automation. The platform serves a broad ecosystem of pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites, helping them accelerate study delivery, reduce operational burden, and bring treatments to patients more efficiently.

Medidata's scale and market presence are substantial: its technology was used in 100% of FDA novel drug approvals in 2025, supports tens of thousands of clinical trials, processes billions of data points annually, and is used by millions of patients worldwide. The company has been recognized by the Everest Group as the highest-placed "Luminary" in its category, a distinction driven by market performance, partnership depth, and the maturity of its AI solutions.

Core Platform Experiences

• Patient Experience: Focused on reducing patient burden across every stage of a clinical trial, enabling more patient-centric research and improving engagement throughout the study lifecycle.
• Data Experience: Leverages AI and automation to streamline data workflows, enabling teams to manage, review, and act on clinical data with greater speed and accuracy.
• Study Experience: Accelerates study delivery through AI-driven insights, helping sponsors and CROs set up and execute trials faster and with greater confidence.

Key Capabilities and Products

• Clinical Data Studio: A solution that harmonizes Clinical Risk Management, Data Management, and Medical Review teams, enabling faster listings at first-patient-in and accelerating both triangular and manual review processes.
• Study Build AI Technology: Deployed to accelerate global clinical pipelines, including an expanded partnership with The Menarini Group focused on oncology programs.
• AI Companions and Orchestrated Intelligence: Advanced AI capabilities showcased at industry events, designed to transform life sciences operations through intelligent automation and decision support.
• Integrations: Medidata integrates with third-party platforms such as CRIO, empowering over 2,500 global research sites with seamless connectivity to accelerate clinical trial execution.

Proven Results Across Customers and Therapeutic Areas

• Quanticate achieved significant reductions in study build times, accelerating go-live and expanding its trial pipeline.
• A global CRO reduced go-live times dramatically, achieving study setup in as little as four to six weeks.
• A mid-sized sponsor increased site count by 50% in a rare disease clinical trial, demonstrating the platform's ability to scale trial operations.
• ICON harmonized its clinical teams through Clinical Data Studio, realizing cost reductions and expedited timelines across data management and medical review functions.

Who Medidata Serves

• Pharmaceutical and biotech sponsors of all sizes, from mid-sized companies to large global enterprises
• Contract Research Organizations (CROs) managing complex, multi-site global trials
• Clinical research sites seeking streamlined integration and operational efficiency
• Cross-functional roles including Data, Operations, IT, and Regulatory teams within clinical organizations

Medidata has received multiple awards and industry recognitions in 2024 and 2025, reinforcing its position as a leading technology partner for life sciences organizations seeking to modernize clinical research and accelerate the path from discovery to approved treatment.